Oncoclinicas do Brasil Servicos Medicos SA
BOVESPA:ONCO3

Watchlist Manager
Oncoclinicas do Brasil Servicos Medicos SA Logo
Oncoclinicas do Brasil Servicos Medicos SA
BOVESPA:ONCO3
Watchlist
Price: 3.33 BRL -7.24% Market Closed
Market Cap: 2.1B BRL
Have any thoughts about
Oncoclinicas do Brasil Servicos Medicos SA?
Write Note

Intrinsic Value

The intrinsic value of one ONCO3 stock under the Base Case scenario is 12.17 BRL. Compared to the current market price of 3.33 BRL, Oncoclinicas do Brasil Servicos Medicos SA is Undervalued by 73%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ONCO3 Intrinsic Value
12.17 BRL
Undervaluation 73%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Oncoclinicas do Brasil Servicos Medicos SA

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for ONCO3 cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about ONCO3?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Oncoclinicas do Brasil Servicos Medicos SA

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Oncoclinicas do Brasil Servicos Medicos SA

Provide an overview of the primary business activities
of Oncoclinicas do Brasil Servicos Medicos SA.

What unique competitive advantages
does Oncoclinicas do Brasil Servicos Medicos SA hold over its rivals?

What risks and challenges
does Oncoclinicas do Brasil Servicos Medicos SA face in the near future?

Summarize the latest earnings call
of Oncoclinicas do Brasil Servicos Medicos SA.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Oncoclinicas do Brasil Servicos Medicos SA.

Provide P/S
for Oncoclinicas do Brasil Servicos Medicos SA.

Provide P/E
for Oncoclinicas do Brasil Servicos Medicos SA.

Provide P/OCF
for Oncoclinicas do Brasil Servicos Medicos SA.

Provide P/FCFE
for Oncoclinicas do Brasil Servicos Medicos SA.

Provide P/B
for Oncoclinicas do Brasil Servicos Medicos SA.

Provide EV/S
for Oncoclinicas do Brasil Servicos Medicos SA.

Provide EV/GP
for Oncoclinicas do Brasil Servicos Medicos SA.

Provide EV/EBITDA
for Oncoclinicas do Brasil Servicos Medicos SA.

Provide EV/EBIT
for Oncoclinicas do Brasil Servicos Medicos SA.

Provide EV/OCF
for Oncoclinicas do Brasil Servicos Medicos SA.

Provide EV/FCFF
for Oncoclinicas do Brasil Servicos Medicos SA.

Provide EV/IC
for Oncoclinicas do Brasil Servicos Medicos SA.

Show me price targets
for Oncoclinicas do Brasil Servicos Medicos SA made by professional analysts.

What are the Revenue projections
for Oncoclinicas do Brasil Servicos Medicos SA?

How accurate were the past Revenue estimates
for Oncoclinicas do Brasil Servicos Medicos SA?

What are the Net Income projections
for Oncoclinicas do Brasil Servicos Medicos SA?

How accurate were the past Net Income estimates
for Oncoclinicas do Brasil Servicos Medicos SA?

What are the EPS projections
for Oncoclinicas do Brasil Servicos Medicos SA?

How accurate were the past EPS estimates
for Oncoclinicas do Brasil Servicos Medicos SA?

What are the EBIT projections
for Oncoclinicas do Brasil Servicos Medicos SA?

How accurate were the past EBIT estimates
for Oncoclinicas do Brasil Servicos Medicos SA?

Compare the revenue forecasts
for Oncoclinicas do Brasil Servicos Medicos SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Oncoclinicas do Brasil Servicos Medicos SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Oncoclinicas do Brasil Servicos Medicos SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Oncoclinicas do Brasil Servicos Medicos SA compared to its peers.

Compare the P/E ratios
of Oncoclinicas do Brasil Servicos Medicos SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Oncoclinicas do Brasil Servicos Medicos SA with its peers.

Analyze the financial leverage
of Oncoclinicas do Brasil Servicos Medicos SA compared to its main competitors.

Show all profitability ratios
for Oncoclinicas do Brasil Servicos Medicos SA.

Provide ROE
for Oncoclinicas do Brasil Servicos Medicos SA.

Provide ROA
for Oncoclinicas do Brasil Servicos Medicos SA.

Provide ROIC
for Oncoclinicas do Brasil Servicos Medicos SA.

Provide ROCE
for Oncoclinicas do Brasil Servicos Medicos SA.

Provide Gross Margin
for Oncoclinicas do Brasil Servicos Medicos SA.

Provide Operating Margin
for Oncoclinicas do Brasil Servicos Medicos SA.

Provide Net Margin
for Oncoclinicas do Brasil Servicos Medicos SA.

Provide FCF Margin
for Oncoclinicas do Brasil Servicos Medicos SA.

Show all solvency ratios
for Oncoclinicas do Brasil Servicos Medicos SA.

Provide D/E Ratio
for Oncoclinicas do Brasil Servicos Medicos SA.

Provide D/A Ratio
for Oncoclinicas do Brasil Servicos Medicos SA.

Provide Interest Coverage Ratio
for Oncoclinicas do Brasil Servicos Medicos SA.

Provide Altman Z-Score Ratio
for Oncoclinicas do Brasil Servicos Medicos SA.

Provide Quick Ratio
for Oncoclinicas do Brasil Servicos Medicos SA.

Provide Current Ratio
for Oncoclinicas do Brasil Servicos Medicos SA.

Provide Cash Ratio
for Oncoclinicas do Brasil Servicos Medicos SA.

What is the historical Revenue growth
over the last 5 years for Oncoclinicas do Brasil Servicos Medicos SA?

What is the historical Net Income growth
over the last 5 years for Oncoclinicas do Brasil Servicos Medicos SA?

What is the current Free Cash Flow
of Oncoclinicas do Brasil Servicos Medicos SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Oncoclinicas do Brasil Servicos Medicos SA.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Oncoclinicas do Brasil Servicos Medicos SA

Current Assets 5B
Cash & Short-Term Investments 2.2B
Receivables 2.4B
Other Current Assets 382.8m
Non-Current Assets 7.3B
Long-Term Investments 127.2m
PP&E 1.4B
Intangibles 4.5B
Other Non-Current Assets 1.3B
Current Liabilities 2.5B
Accounts Payable 1.1B
Accrued Liabilities 385m
Other Current Liabilities 1.1B
Non-Current Liabilities 5.9B
Long-Term Debt 4.8B
Other Non-Current Liabilities 1.1B
Efficiency

Earnings Waterfall
Oncoclinicas do Brasil Servicos Medicos SA

Revenue
6.1B BRL
Cost of Revenue
-4.1B BRL
Gross Profit
2B BRL
Operating Expenses
-1.3B BRL
Operating Income
756.4m BRL
Other Expenses
-684m BRL
Net Income
72.4m BRL

Free Cash Flow Analysis
Oncoclinicas do Brasil Servicos Medicos SA

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

In Q2 2024, Oncoclínicas delivered 16% revenue growth, reaching BRL 1.7 billion, driven by increased treatment volumes and higher average ticket prices. The company’s EBITDA improved to BRL 300 million, with a margin of 19.2%, up 270 basis points sequentially due to disciplined cost control. Net income grew 16% from the previous quarter to BRL 300 million. Despite challenges such as floods in Rio Grande do Sul, operational efficiency improved, cash operating expenses reduced, and leverage decreased to 2.5x EBITDA. The oncology market's annual growth of 13% positions Oncoclínicas for continued market share gains.

What is Earnings Call?
Fundamental Scores

ONCO3 Profitability Score
Profitability Due Diligence

Oncoclinicas do Brasil Servicos Medicos SA's profitability score is 49/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Positive Gross Profit
ROE is Increasing
Positive Revenue Growth Forecast
49/100
Profitability
Score

Oncoclinicas do Brasil Servicos Medicos SA's profitability score is 49/100. The higher the profitability score, the more profitable the company is.

ONCO3 Solvency Score
Solvency Due Diligence

Oncoclinicas do Brasil Servicos Medicos SA's solvency score is 35/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Average D/E
Positive Net Debt
35/100
Solvency
Score

Oncoclinicas do Brasil Servicos Medicos SA's solvency score is 35/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ONCO3 Price Targets Summary
Oncoclinicas do Brasil Servicos Medicos SA

Wall Street analysts forecast ONCO3 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ONCO3 is 8.47 BRL with a low forecast of 5.76 BRL and a high forecast of 13.65 BRL.

Lowest
Price Target
5.76 BRL
73% Upside
Average
Price Target
8.47 BRL
154% Upside
Highest
Price Target
13.65 BRL
310% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for ONCO3?

Click here to dive deeper.

Dividends

Oncoclinicas do Brasil Servicos Medicos SA
does not pay dividends
Shareholder Yield

Current shareholder yield for ONCO3 is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Oncoclinicas do Brasil Servicos Medicos SA Logo
Oncoclinicas do Brasil Servicos Medicos SA

Country

Brazil

Industry

Health Care

Market Cap

2.1B BRL

Dividend Yield

0%

Description

Oncoclínicas do Brasil Serviços Médicos SA operates as a holding company, which engages in oncology clinics through the health care segment. The company is headquartered in Sao Paulo, Sao Paulo. The company went IPO on 2021-08-10. The firm provides of medical services focused on Oncology. The Company, since its foundation, in addition to acting directly in the treatment of cancer patients, has dedicated itself to the study and identification of the appropriate therapy opportunities for patients and the growth trends in the sector. The firm holds interest in a number of subsidiaries, such as Centro de Quimioterapia Antiblastica e Imunoterapia SA, Centro Mineiro de Infusoes SA, and Centro Paulista de Oncologia SA.

Contact

SAO PAULO
Sao Paulo
Avenida Presidente Juscelino Kubitschek, n 510 2 andar, Vila Nova Conceicao
+551126787474
www.grupooncoclinicas.com

IPO

2021-08-10

Employees

-

Officers

Vice Chairman & CEO
Mr. Bruno Lemos Ferrari
Chief Financial and Investor Relations Officer
Mr. Cristiano Affonso Ferreira de Camargo
Director of M&A and Operations
Mr. Raoni Larena
Chief Technology Officer
Mr. Ricardo da Silva Santoro
Director of Compliance & Legal
Ms. Cinthia Maria Ambrogi
Marketing Officer
Guilherme Gimenes Ferri
Show More
Human Resources Officer
Mr. Giovane Reus Nichele da Costa
Chief Strategy Officer & Board Member
Mr. Joao Carlos Figueiredo Padin
Show Less

See Also

Discover More
What is the Intrinsic Value of one ONCO3 stock?

The intrinsic value of one ONCO3 stock under the Base Case scenario is 12.17 BRL.

Is ONCO3 stock undervalued or overvalued?

Compared to the current market price of 3.33 BRL, Oncoclinicas do Brasil Servicos Medicos SA is Undervalued by 73%.

Back to Top